Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 22 Sept 2026 for Atrium Therapeutics, Inc., €91k.
Filing timeline
BuySaleKathleen P. Gallagher
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kathleen P. Gallagher: trading record in brief
Kathleen P. Gallagher is a declared insider at 2 companies; the most frequent names are Avidity Biosciences, Inc. and Atrium Therapeutics, Inc. The record holds 25 filings, for trades running from 6 January 2025 to 18 September 2026.
Sales make up the whole of the open-market record (12 sales, €1.1M). Besides market trades, the filings include 6 share grants and 6 option exercises.
The record was last updated on 22 September 2026 with a share grant (€91k) in Atrium Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kathleen P. Gallagher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
11,632 shares@ US$8.95Common StockSEC:0001193125-26-397944:0
102,500 shares0Common StockSEC:0001193125-26-170914:0
80,303 sharesCommon StockSEC:0001193125-26-082228:0
72,000 shares0Common StockSEC:0001599901-25-000215:0
188 shares@ US$47.422.0% of flowCommon StockSEC:0001599901-25-000171:0
911 shares@ US$30.244.9% of flowCommon StockSEC:0001599901-25-000131:0
5,875 shares@ US$16.6518.2% of flowCommon StockSEC:0001599901-25-000109:0
5,875 shares@ US$16.6522.6% of flowCommon StockSEC:0001599901-25-000097:0
5,546 shares@ US$14.7019.7% of flowCommon StockSEC:0001599901-25-000079:0
5,875 shares@ US$14.7021.6% of flowCommon StockSEC:0001599901-25-000061:0
5,875 shares@ US$16.6524.9% of flowCommon StockSEC:0001599901-25-000045:0
1,295 shares@ US$28.599.3% of flowCommon StockSEC:0001599901-25-000033:0
25,000 shares0Common StockSEC:0001599901-25-000017:0
13 of 13 declarations
